ABSTRACT Viral or bacterial co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in the literature. However, the knowledge on Aspergillus co-infection among patients with coronavirus disease 2019 (COVID-19) is limited. COVID‐19‐associated pulmonary aspergillosis (CAPA) has been seen in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS), which has raised concerns about the worsening disease course of COVID-19 and increasing mortality. We describe a clinical case of CAPA infection and acute respiratory distress syndrome (ARDS) with a deathly outcome in a previously well, non-immunocompromised pregnant woman with intrauterine death of the fetus. Hence, we suggest that clinicians and pathologists keep alerting the possible occurrence of pulmonary aspergillosis in severe/critical COVID-19 patients, and aggressive investigations should be done to rule out the possibility of CAPA so that early treatment can be administrated.
【저자키워드】 SARS-CoV-2, fungi, COVID-19, Pulmonary Aspergillosis, Respiratory Distress Syndrome,, 【초록키워드】 COVID-19, coronavirus disease, ARDS, coronavirus, Mortality, knowledge, Infection, outcome, Pregnant woman, Critically ill, early treatment, Patient, Co-infection, death, Aspergillus, bacterial co-infection, COVID-19 patients, acute respiratory distress, COVID-19 patient, acute respiratory syndrome, clinician, pathologist, worsening, disease course, syndrome, Occurrence, reported, raised, 【제목키워드】 COVID-19, Pregnant woman,